Healthy Infants

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

I
IQVIANC - Durham
1 program
Control 1st age starter infant formulaN/A1 trial
Active Trials
NCT06073652Active Not Recruiting240Est. Sep 2027

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
IQVIAControl 1st age starter infant formula

Clinical Trials (1)

Total enrollment: 240 patients across 1 trials

NCT06073652IQVIAControl 1st age starter infant formula

Starter Infant Formula With Synbiotics

Start: Jul 2023Est. completion: Sep 2027240 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space